Literature DB >> 9393881

Deletional remodeling of c-myc-deregulating chromosomal translocations.

A L Kovalchuk1, J R Müller, S Janz.   

Abstract

Evidence is presented for the existence of a novel remodeling-by-deletion mechanism that alters the fine structure of c-myc-deregulating chromosomal translocations in t(12;15)-positive BALB/c plasmacytomas. DNA sequence analysis of the t(12;15) in five primary tumors revealed the co-existence of precursor cells harboring genetic recombinations between the immunoglobulin heavy-chain mu locus (Igh mu) and c-myc with clonally related progenitors containing rearrangements between the immunoglobulin heavy-chain alpha locus (Igh alpha) and c-myc. Clonal relatedness was based upon unique junction fragments between the switch region of Igh mu and c-myc. S mu/c-myc junctions are thus useful clonotypic markers for monitoring the conversion of Igh mu/c-myc-positive tumor precursor clones into Igh alpha/c-myc-positive plasmacytomas. Aberrant isotype switch recombination appears to be the most likely mechanism effecting this conversion event (other possibilities are discussed) which may help to explain the preferred usage of the Igh alpha locus in recombinations with c-myc in t(12;15)-positive plasma cell tumors in BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393881     DOI: 10.1038/sj.onc.1201409

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Genetic reporter system for oncogenic Igh-Myc translocations in mice.

Authors:  M Takizawa; J S Kim; L Tessarollo; N McNeil; T J Waldschmidt; R Casellas; T Ried; S Janz
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

2.  IL-6 transgenic mouse model for extraosseous plasmacytoma.

Authors:  Alexander L Kovalchuk; Joong Su Kim; Sung Sup Park; Allen E Coleman; Jerrold M Ward; Herbert C Morse; Tadamitsu Kishimoto; Michael Potter; Siegfried Janz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 3.  Impact of alternative DNA structures on DNA damage, DNA repair, and genetic instability.

Authors:  Guliang Wang; Karen M Vasquez
Journal:  DNA Repair (Amst)       Date:  2014-04-21

4.  Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice.

Authors:  Chen-Feng Qi; Dong-Mi Shin; Zhaoyang Li; Hongsheng Wang; Jianxum Feng; Janet W Hartley; Torgny N Fredrickson; Alexander L Kovalchuk; Herbert C Morse
Journal:  J Pathol       Date:  2010-05       Impact factor: 7.996

5.  MRE11 Promotes Tumorigenesis by Facilitating Resistance to Oncogene-Induced Replication Stress.

Authors:  Elizabeth Spehalski; Kayla M Capper; Cheryl J Smith; Mary J Morgan; Maria Dinkelmann; Jeffrey Buis; JoAnn M Sekiguchi; David O Ferguson
Journal:  Cancer Res       Date:  2017-08-17       Impact factor: 12.701

6.  Amino-terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc/IgH translocation.

Authors:  Anna Gazumyan; Ksenia Timachova; Grace Yuen; Edward Siden; Michela Di Virgilio; Eileen M Woo; Brian T Chait; Bernardo Reina San-Martin; Michel C Nussenzweig; Kevin M McBride
Journal:  Mol Cell Biol       Date:  2010-12-06       Impact factor: 4.272

7.  Naturally occurring H-DNA-forming sequences are mutagenic in mammalian cells.

Authors:  Guliang Wang; Karen M Vasquez
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

Review 8.  DNA triple helices: biological consequences and therapeutic potential.

Authors:  Aklank Jain; Guliang Wang; Karen M Vasquez
Journal:  Biochimie       Date:  2008-02-21       Impact factor: 4.079

Review 9.  Models for chromosomal replication-independent non-B DNA structure-induced genetic instability.

Authors:  Guliang Wang; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2009-04       Impact factor: 4.784

10.  Estrogen directly activates AID transcription and function.

Authors:  Siim Pauklin; Isora V Sernández; Gudrun Bachmann; Almudena R Ramiro; Svend K Petersen-Mahrt
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.